microinjections of scopolamine or a specific m2 muscarinic receptor antagonist ( afdx-116 ) into the vlpa prevented the pressor and tachycardic responses to subsequent microinjections of dap at the same sites indicating that the responses were mediated via m2 receptors .
C0036442
scopolamine
C0039231
tachycardic